logo
  Join        Login             Stock Quote

Invacare (IVC) To Sell Domestic Medical Supplies Business To Assuramed

 December 21, 2012 10:53 AM
 


(By Balaseshan) Invacare Corp. (NYSE: IVC), a maker of medical equipments used in home, said it has agreed to sell its domestic medical supplies business to AssuraMed for $150 million.

This divestiture of Invacare Supply Group (ISG) is consistent with Invacare's focus on its globalization strategy to harmonize core global product lines and reduce complexity within its business. While expected to be initially dilutive, this divestiture is consistent with Invacare's globalization strategy.

For AssuraMed, which focuses in wholesale and home-delivered medical supplies across the United States, this strategic purchase allows the company to strengthen its position as a leader in the medical supplies industry.

[Related -Insider Weekends – May 3, 2013]

Invacare preliminarily estimates that it will realize net proceeds from the sale of the ISG business of about $140 million, net of tax and expenses. In the near term, Invacare plans to use the proceeds to strengthen its balance sheet and reduce debt outstanding under its revolving credit facility.

As previously disclosed by Invacare, net sales for the ISG business were about $299.5 million for 2011 and $246.4 million for the first nine months of 2012. Earnings before income taxes were about $8.0 million for 2011 and $5.1 million for the first nine months of 2012.

"This divestiture represents a significant step forward for Invacare and it allows us to continue to reduce complexity in our business, focus on our core product lines and expand globally, with the long-term goal of returning operating margins back to high single digits," said Gerald Blouch, Invacare President and Chief Executive Officer.

[Related -Invacare (IVC) To Cut Workforce At Taylor Street Manufacturing Facility In Elyria, Ohio]

The transaction is expected to close in early 2013. Jefferies & Co. Inc. acted as financial adviser and Calfee, Halter & Griswold LLP acted as legal adviser to Invacare in the transaction.

IVC is trading down 0.57% at $15.65 on Friday. The stock has been trading between $12.87 and $19.25 for the past 52 weeks.

iOnTheMarket Premium
Advertisement

Advertisement


Post Comment -- Login is required to post message
Name:  
Alert for new comments:
Your email:
Your Website:
Title:
Comments:
 

rss feed

Latest Stories

article imageThe Sixty Percent Alibaba Play No One Is Talking About

It's official: Chinese e-commerce juggernaut Alibaba (NYSE: BABA) goes down as the biggest U.S. IPO in read on...

article imageThe Finer Points Of Hedging… Or Not

Barry Ritholtz asks the right question—Why hedge?–in the wake of last week’s announcement that California read on...

article imageBulls Leverage Hopeful News to Launch a Tepid Breakout Attempt

Stocks were able to leverage some optimistic news and dovish words from the Fed to take another stab at an read on...

article imageG-20 Minus One Country Plus 900 Bullet Points Equal 2 Percentage Points of Extra Growth?

For investors, the G-20’s super-secret plan to make the world grow faster is more a sideshow than a reason read on...

Advertisement
Popular Articles

Advertisement
Daily Sector Scan
Partner Center

Related Articles:

Why Zillow Trumps Linkedin For Our Portfolio
More Articles on: Medical



Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia.
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.